Measles-containing-vaccine second-dose (MCV2) immunization coverage in Andorra
Andorra: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 96.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Andorra, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Andorra is 96.0%, measured in 2025.
That represents a change of down 1.0% on the previous year and up 9.1% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Andorra peaked at 97.0% in 2019 and was at its lowest, 0.0%, in 2000.
That places Andorra 26th out of 194 countries with data for 2025, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 24.8% | 0.0% | 86.0% | 10 |
| 2010s | 90.2% | 82.0% | 97.0% | 10 |
| 2020s | 95.8% | 93.0% | 97.0% | 6 |
Countries ranked near Andorra
- 23 Guyana 97.0% compare
- 23 Seychelles 97.0% compare
- 23 Tunisia 97.0% compare
- 26 Trinidad and Tobago 96.0% compare
- 26 Egypt 96.0% compare
- 29 India 95.0% compare
- 29 Uruguay 95.0% compare
- 29 Norway 95.0% compare
- 29 Mongolia 95.0% compare
- 29 Japan 95.0% compare
- 29 Viet Nam 95.0% compare
- 29 Korea 95.0% compare
- 29 Portugal 95.0% compare
- 29 Russian Federation 95.0% compare
- 29 Armenia 95.0% compare
- 29 Tuvalu 95.0% compare
- 29 Sri Lanka 95.0% compare
- 29 United States 95.0% compare
- 29 Nicaragua 95.0% compare
More health data for Andorra
- Heat deaths vs projected death rates 1,824 (2090)
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2077)
- Heat deaths vs projected death rates, annual growth rate 0.0878 % change on previous year (2090)
- Un projection of annual infant deaths 0 (2100)
- Age population, age 07, female, interpolated 296 (2025)
- Age population, age 09, male, interpolated 371 (2025)
- Age population, age 09, female, interpolated 345 (2025)
- Age population, age 08, male, interpolated 358 (2025)
- Age population, age 08, female, interpolated 329 (2025)
- Age population, age 07, male, interpolated 329 (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Andorra?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Andorra was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Andorra?
- The highest recorded value was 97.0% in 2019.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Andorra?
- The lowest recorded value was 0.0% in 2000.
- How does Andorra rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Andorra ranks 26th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Andorra?
- Over the last ten years it is up 9.1%. The long-run trend across the full record is volatile.
- Where does this Andorra data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).